Baxter Reports First-Quarter 2024 Results
First-quarter sales from continuing operations of $3.59 billion increased 2% on a reported basis and 3% on a constant currency basis, exceeding the company’s previously issued...
Source: marketscreener.com
Dextrose Injection News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Dextrose Injection. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Dextrose Injection Today - Breaking & Trending Today
Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S.
Five new launches reinforce Baxter’s focus on differentiated products and enhance the company’s Pharmaceuticals portfolio in critical therapeutic areas Products feature ready-to-use...
Source: marketscreener.com
Hikma exceeds 150 injectable medicines in the US with launch of Dobutamine Injection, USP
/PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, has launched Dobutamine Injection, USP, in a 250mg/20mL vial in...
Source: prnewswire.com
American Regent Launches a New Vial Presentation
/PRNewswire/ -- American Regent, Inc. and Provepharm Life Solutions are pleased to announce the availability of ProvayBlue® (methylene blue) Injection, USP in...
Source: prnewswire.com
Frontiers | Review: Insights on Current FDA-Approved Monoclonal Antibodies Against Ebola Virus Infection
1 Abstract The devastating Ebola outbreak in West Africa in 2013-2016 accelerated the progress of several medical countermeasures (MCMs) against Ebola virus disease (EVD). Several IPs were used during that outbreak, but no conclusion on efficacy could be drawn. Only the Randomized Controlled Trial (RCT) on ZMapp was promising but inconclusive. More recently, during the second largest Ebola outbreak in North Kivu and Ituri provinces, Democratic Republic of the Congo (DRC), four IPs (Remdesivir, Regeneron, ZMapp and MAb114) have been evaluated in a RCT, the Pamoja Tulinde Maisha (PALM) study. Tw...
Source: frontiersin.org